LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

Search

Simulations Plus Inc

Cerrado

SectorSanidad

19.53

Resumen

Variación precio

24h

Actual

Mínimo

19.3

Máximo

19.87

Métricas clave

By Trading Economics

Ingresos

-70M

-67M

Ventas

-2.1M

20M

P/B

Media del Sector

48.528

80.03

Rentabilidad por dividendo

0.48

Margen de beneficios

-330.585

Empleados

243

EBITDA

327K

5.3M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+4.38% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.29%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-7M

344M

Apertura anterior

19.53

Cierre anterior

19.53

Noticias sobre sentimiento de mercado

By Acuity

29%

71%

64 / 374 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

8 dic 2025, 23:48 UTC

Principales Movimientos del Mercado

Shares of Sezzle and Vital Farms Rise on S&P SmallCap 600 Inclusion

8 dic 2025, 23:44 UTC

Charlas de Mercado

Perky Australian Dollar Looks to Extend Gains -- Market Talk

8 dic 2025, 23:42 UTC

Charlas de Mercado

Nikkei May Decline Amid Uncertainty Over Econ, Earnings -- Market Talk

8 dic 2025, 23:13 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

8 dic 2025, 23:13 UTC

Charlas de Mercado

Australian Inflation Expectations Highest Since Late 2023 -- Market Talk

8 dic 2025, 23:09 UTC

Adquisiciones, fusiones, absorciones

Paramount Made a Hostile Bid for Warner After Netflix Deal. What Happens Next? -- WSJ

8 dic 2025, 22:46 UTC

Charlas de Mercado

Rio Tinto Building Low-Cost Lithium Business in Difficult Market -- Market Talk

8 dic 2025, 22:01 UTC

Charlas de Mercado

Miners Poised to Do Well in 2026 -- Market Talk

8 dic 2025, 22:00 UTC

Adquisiciones, fusiones, absorciones

Noble: Agreement With Borr Includes Sale of Noble Tom Prosser, Noble Mick O'Brien, Noble Regina Allen, Noble Resilient, Noble Resolute, Closing Expected in Early 2026 >NE

8 dic 2025, 22:00 UTC

Adquisiciones, fusiones, absorciones

Noble: Agreement With Borr Comprises $210M in Cash and $150M in Seller Notes >NE

8 dic 2025, 22:00 UTC

Adquisiciones, fusiones, absorciones

Noble: Agreement With Ocean Oilfield Drilling Anticipates the Sale of the Noble Resolve, Closing Is Expected in 2Q 2026, Upon Conclusion of Noble Resolve's Current Contract >NE

8 dic 2025, 22:00 UTC

Adquisiciones, fusiones, absorciones

Noble: To Sell Five Rigs to Borr Drilling Limited for $360M and One Rig to Ocean Oilfield Drilling for $64M in Cash >NE

8 dic 2025, 21:51 UTC

Charlas de Mercado

US-Canada Rate Spreads Narrow Sharply After Record Gap -- Market Talk

8 dic 2025, 21:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

8 dic 2025, 21:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

8 dic 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

8 dic 2025, 21:38 UTC

Adquisiciones, fusiones, absorciones

Boeing Buys Company Responsible for Door Blowout. The Stock Rises. -- Barrons.com

8 dic 2025, 21:38 UTC

Adquisiciones, fusiones, absorciones

Paramount Makes $77.9 Billion Hostile Bid for Warner After Netflix Struck Deal -- 7th Update

8 dic 2025, 21:36 UTC

Charlas de Mercado

Oil Oversupply to Show Up As Waterborne Stocks Land -- Market Talk

8 dic 2025, 21:20 UTC

Adquisiciones, fusiones, absorciones

Will the Netflix-Warner Bros. Merger Go Through? It Depends on How You Define Market Share. -- Barrons.com

8 dic 2025, 21:12 UTC

Adquisiciones, fusiones, absorciones

These Stocks Moved the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

8 dic 2025, 21:08 UTC

Charlas de Mercado

Rosenberg Turns 'Outright Bullish' on Canada Dollar -- Market Talk

8 dic 2025, 20:38 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Netflix Co-CEOs Confident About Regulatory Approval for WBD Deal -- Market Talk

8 dic 2025, 20:26 UTC

Adquisiciones, fusiones, absorciones

These Stocks Are Moving the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

8 dic 2025, 20:18 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Netflix Isn't Looking to Make Cuts at Warner Bros. Discovery -- Market Talk

8 dic 2025, 20:07 UTC

Charlas de Mercado

Oil Futures Snap Three-Session Winning Streak -- Market Talk

8 dic 2025, 20:06 UTC

Charlas de Mercado

U.S. Natural Gas Pulls Back From Weather-Driven Highs -- Market Talk

8 dic 2025, 20:05 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

8 dic 2025, 20:05 UTC

Charlas de Mercado

Deere Offers Sales Growth Forecast Through 2030 -- Market Talk

8 dic 2025, 20:01 UTC

Charlas de Mercado

Precious Metals Slip Ahead of Fed Decision -- Market Talk

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

4.38% repunte

Estimación a 12 Meses

Media 20.5 USD  4.38%

Máximo 25 USD

Mínimo 16 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

3

Comprar

2

Mantener

0

Vender

Sentimiento

By Acuity

64 / 374 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat